Stefan K.f. Schwabe, Executive Vice President R&D at SUPERNUS PHARMACEUTICALS INC (SUPN), sold 2,051 shares at $18.27 ($37K) on 2015-06-12, disclosed to the SEC on 2015-06-15.
Scheduled sale ($37k) by Executive Vice President R&D under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| SUPN | SELL | 2018-06-19 | $3.3M | — | Filing → |
| SUPN | SELL | 2017-09-11 | $4.4M | — | Filing → |
| SUPN | SELL | 2015-07-29 | $50K | — | Filing → |